The main objective of this project is to develop a tool for immunological and molecular characterisation for non-small-cell lung cancer patients in order to find a molecular signature that allows the stratification of patients regarding immunotherapy. It aims to integrate clinical, molecular, and immunological data specific to the tumour and identify the long-term survivors with these treatments. It is currently impossible to predict long-term survivors in advance using any known parameters.
patients diagnosed with lung cancer participate in the project